AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2023
Dec 8, 2023
32180_dirs_2023-12-08_99f8b217-1779-402d-bd3b-5a9289dd0f93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2023-12-07
Reporting Person: Davidson Nancy (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-07 | Stock Option (Right to Buy) | $9.55 | A | 74000 | Acquired | 2033-12-06 | Common Stock (74000) | Direct |
Footnotes
F1: Stock options vest in 36 equal monthly installments starting one month after grant date of December 7, 2023.